Published in Br Med J on September 16, 1972
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
The "top 50": a perspective on the BMJ drawn from the Science Citation Index. BMJ (1990) 1.07
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. J Clin Invest (1980) 1.03
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest (1979) 0.99
Prolactinoma: a question of rational treatment. Br Med J (Clin Res Ed) (1981) 0.96
Hypothalamic regulatory hormones: a review. J Clin Pathol (1974) 0.91
Disorders of prolactin secretion. J Clin Pathol Suppl (Assoc Clin Pathol) (1976) 0.90
An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea. Br Med J (1975) 0.89
Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol (1980) 0.87
Lactation and the physiology of prolactin secretion. Postgrad Med J (1975) 0.81
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. Proc Natl Acad Sci U S A (1981) 0.79
Bromocriptine therapy in acromegaly. A long-term review of 35 cases. Postgrad Med J (1981) 0.78
[Hyperprolactinemia and sterility]. Arch Gynecol (1979) 0.76
Prolactin and human reproduction. Can Med Assoc J (1976) 0.75
Levodopa in Forbes-Albright syndrome. Can Med Assoc J (1973) 0.75
Physiological actions of prolactin. Proc R Soc Med (1973) 0.75
Cabergoline therapy for macroprolactinoma during pregnancy: a case report. BMC Res Notes (2012) 0.75
Clinical infertility in women. Environ Health Perspect (1978) 0.75
Bromocriptine for subfertile males. J Natl Med Assoc (1980) 0.75
Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy. Arch Gynakol (1975) 0.75
Bioassay of prolactin. Proc R Soc Med (1973) 0.75
Amenorrhœa and galactorrhœa. Proc R Soc Med (1973) 0.75
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A (1971) 3.36
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]. Experientia (1968) 2.33
Stimulation tests of pituitary-Leydig cell function in normal male subjects and hypogonadal men. Clin Endocrinol (Oxf) (1972) 1.58
Human prolactin: measurement in plasma by in vitro bioassay. J Clin Invest (1971) 1.49
Plasma prolactin activity in inappropriate lactation. Br Med J (1971) 1.46
Treatment of non-puerperal galactorrhoea with an ergot alkaloid. Br Med J (1971) 1.43
Levodopa suppression of prolactin in nonpuerperal galactorrhea. N Engl J Med (1971) 1.41
Human prolactin. Evidence obtained by the bioassay of human plasma. J Endocrinol (1971) 1.34
Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology (1972) 1.27
Functional evaluation of prolactin secretion: a guide to therapy. J Clin Invest (1972) 1.22
Galactorrhoea. Br Med J (1972) 1.19
Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology (1971) 1.18
Suppression of puerperal lactation with an ergot alkaloid: a double-blind study. Br Med J (1972) 1.17
[Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture]. Ann Endocrinol (Paris) (1971) 1.13
Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154). Experientia (1971) 1.03
Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice. Experientia (1970) 0.91
Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa. J Clin Endocrinol Metab (1972) 0.91
Evidence of antagonism between prolactin and gonadotrophin secretion: effect of methalibure on perphenazine-induced prolactin secretion inovariectomized rats. J Endocrinol (1971) 0.90
Pituitary portal vessel infusion of hypothalamic extract and release of LH, FSH and prolactin. Endocrinology (1971) 0.84
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Glucocorticoid exposure in utero: new model for adult hypertension. Lancet (1993) 3.47
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A (1997) 3.00
Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet (1990) 2.87
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet (1987) 2.50
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel. Br Med J (1967) 2.39
A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab (1999) 2.30
Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 2.06
Corticosteroid treatment and surgery. 1. An investigation of the indications for steroid cover. Anaesthesia (1969) 2.00
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J (1974) 1.98
Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet (1980) 1.94
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature (1974) 1.92
Radioimmunoassay of human prolactin. Proc R Soc Med (1973) 1.81
Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet (1985) 1.81
Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta (1996) 1.75
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) (1993) 1.69
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
5 alpha-reductase activity in polycystic ovary syndrome. Lancet (1990) 1.68
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br Med J (Clin Res Ed) (1983) 1.67
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62
Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet (1991) 1.61
Apathetic T-3 toxicosis. Br Med J (1974) 1.61
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Functional localization of single active ion channels on the surface of a living cell. Nat Cell Biol (2000) 1.60
Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59
Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab (1996) 1.59
Consensus statement on the use of breastfeeding as a family planning method. Contraception (1989) 1.59
Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) (1997) 1.58
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest (1999) 1.55
Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab (2000) 1.52
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med (1989) 1.52
Pituitary-adrenal function in severe depressive illness. Lancet (1968) 1.52
Cell type-specific adenoviral transgene expression in the intact ovine pituitary gland after stereotaxic delivery: an in vivo system for long-term multiple parameter evaluation of human pituitary gene therapy. Endocrinology (2001) 1.52
Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab (1996) 1.52
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49
Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J (1975) 1.49
Letter: Metaclopramide and prolactin. Br Med J (1974) 1.48
Plasma prolactin activity in inappropriate lactation. Br Med J (1971) 1.46
Immunoreactive corticotrophin levels in adrenocortical insufficiency. Br Med J (1971) 1.46
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol (Oxf) (2000) 1.45
Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet (1974) 1.45
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest (1988) 1.44
Cushing's syndrome. Clin Endocrinol Metab (1985) 1.44
Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA). Biol Reprod (2010) 1.43
Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11 beta-hydroxysteroid dehydrogenase. Clin Endocrinol (Oxf) (1993) 1.43
Colorectal neoplasia in acromegaly. Gut (1999) 1.42
Osmotic and non-osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking. Clin Endocrinol (Oxf) (1991) 1.42
Lymphocytic hypophysitis: unusual features of a rare disorder. Clin Endocrinol (Oxf) (1995) 1.41
A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet (1988) 1.40
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40
Late diagnosis of pituitary and parapituitary lesions causing visual failure. Br Med J (Clin Res Ed) (1986) 1.40
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol (Oxf) (1996) 1.40
The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 1.39
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndrome. Clin Endocrinol (Oxf) (1994) 1.39
Cerebral vasospasm following subarachnoid hemorrhage: effect of calcitonin gene-related peptide on middle cerebral artery velocities using transcranial Doppler sonography. Surg Neurol (1991) 1.38
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology (1995) 1.38
Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension (1996) 1.37
Prolactin, TSH, LH and FSH responses to a combined LHRH-TRH test at different stages of the menstrual cycle. Clin Endocrinol (Oxf) (1974) 1.37
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.37
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol (1970) 1.35
Human prolactin. Evidence obtained by the bioassay of human plasma. J Endocrinol (1971) 1.34
Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet (1995) 1.32
Prolactinomas. Br Med J (Clin Res Ed) (1985) 1.32
Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) (1994) 1.32
Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet (1979) 1.31
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31
Theca: the forgotten cell of the ovarian follicle. Reproduction (2010) 1.29
The development of a radioimmunoassay and a plasma extraction method for vasopressin. J Endocrinol (1970) 1.28
Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem (1979) 1.26
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol (2003) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab (2000) 1.26
Influence of amphetamines on plasma corticosteroid and growth hormone levels in man. Br Med J (1969) 1.25
Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin. Br Med J (1971) 1.25